• share
• favorite_border

Recent guidelines have restricted aspirin use for primary cardiovascular disease prevention, with the AHA/ACC restricting it to patients under 70 and the U.S. Preventive Services Task Force further restricting it to those under 60, even though heart attack and stroke risks increase with age. Researchers argue they were overly influenced by the flawed ASPREE trial, which failed to provide reliable evidence of aspirin鈥檚 efficacy in the enrolled age groups, and that proper statistical principles must guide trial design, analysis, and interpretation to avoid misleading conclusions.

• share
• favorite_border

Study led by Mount Sinai researcher could lead to more widespread use of imaging technique to improve survival and prevent complications

• share
• favorite_border

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated. Researchers from UC San Francisco (UCSF) and Mass General Brigham found that electronic messages sent to providers within one week of patients receiving an echocardiogram improved care for patients with severe AS 鈥� including higher rates of treatment with aortic valve replacement (AVR), particularly in symptomatic patients.

• share
• favorite_border

South Africa鈥檚 2013 sodium reduction law is lowering blood pressure and improving health. A study by Wits & Harvard found a 10% drop in sodium intake, with stricter limits in processed foods. Even small reductions cut heart disease risk. Experts say more countries should follow suit. #PublicHealth

• share
• favorite_border

Trial led by Mount Sinai researcher could save lives for patients in need of urgent surgery, invasive procedures, or experiencing major bleeding

• share
• favorite_border

Atrial fibrillation (AFib) is the most common type of heart arrhythmia impacting more than 5 million people in the United States, a number that is anticipated to reach 12.1 million by 2030. The heart rhythm condition is characterized by fast and irregular heartbeats from the upper chambers of the heart. People with AFib are at increased risk of stroke, heart failure, dementia, and premature death.

• share
• favorite_border

MINNEAPOLIS 鈥� People who have early signs of heart problems may also have changes in brain health that can be early signs of dementia, such as loss of brain volume, according to a meta-analysis published on March 26, 2025, online in Neurology庐, the medical journal of the American Academy of Neurology. The meta-analysis does not prove that early heart problems cause loss of brain cells; it only shows an association.

• share
• favorite_border

Stroke survivors who have attended some level of higher education may face even steeper mental declines, according to a study led by Michigan Medicine. The findings suggest that attending higher education may enable people to retain greater cognitive ability until a critical threshold of brain injury is reached after a stroke.

• share
• favorite_border

Debabrata Mukherjee, M.D., M.S., and Salma Elwazeer, B.D.S., M.D.S., M.P.H., were recognized for their outstanding contributions to academia and health sciences, highlighting their dedication to advancing education, research and patient care.

• share
• favorite_border

A scientific technique that rapidly increases the body鈥檚 production of anti-inflammatory cells promoted healing from heart attacks in mice, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai.

• share
• favorite_border

Physicians and investigators from the Smidt Heart Institute at Cedars-Sinai will present research and be honored for their ongoing work in cardiovascular research and care during the American College of Cardiology鈥檚 Annual Scientific Session taking place March 29-31 in Chicago.

• share
• favorite_border

Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. 鈥淐hip鈥� Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious Mayo Clinic Proceedings highlighting the comparative efficacy of lipid-lowering therapies for reducing cardiovascular risks and led by Maciej Banach, MD,PhD from Poland and leader of the International Lipid Expert Panel ( ILEP).

• share
• favorite_border

For human health, prematurely aging cells are a big problem. When a cell ages and stops growing, its function changes, which can cause or worsen cardiovascular disease, Alzheimer鈥檚 disease and other chronic diseases. But these cells are also like needles in a haystack, difficult to identify by traditional scientific measures.

• share
• favorite_border

Cedars-Sinai investigators have developed a novel artificial intelligence (AI) model, named DYNA, that accurately distinguishes harmful gene variations from harmless ones, potentially enhancing physicians鈥� ability to diagnose diseases. The new tool could pave the way for more precise personalized medicine and targeted therapies.

• share
• favorite_border

A one of its kind study has uncovered the significant role that environmental pollution and healthcare disparities play in the prevalence of congenital heart defects in Mexico.